Cutaneous lupus erythematosus (CLE) is a rare autoimmune disease with a heterogeneous spectrum of clinical manifestations on the skin. Prof. Dr. med. Luca Borradori, Chief Physician and Clinic Director of Dermatology at Inselspital Bern, gave an up-to-date overview of the diagnostic clarifications to be carried out in the event of a clinical suspicion of CLE and the treatment options available. With adequate disease management, many CLE patients can maintain a good quality of life.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Atrial fibrillation
What’s new with the “pace-and-ablate” strategy?
- De-escalation strategies
De-escalation strategies – less is more
- Pathogens in the brain
When infections trigger strokes
- Pulmonary hypertension
PH and lung diseases
- Diabetes mellitus
Treatment of comorbidities in older people
- Advanced NSCLC
MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC
- Atopic dermatitis and allergies Atopic dermatitis and allergies
Type 2 inflammation and other factors
- Idiopathic cholestasis